TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has entered into a definitive agreement with a syndicate of high quality healthcare investors for the private placement of up to $25,913,550,
August 11, 2020
· 4 min read